EN
HI
Summary
As of 10 Oct, 2026, Jubilant Pharmova stock price is ₹931.9. During the trading session, the stock has moved between an intraday low of ₹917.60 and an intraday high of ₹950.00. Over the last 52 weeks, Jubilant Pharmova has traded between ₹786.05 and ₹1184.80.
The stock has recorded a trading volume of 1,23,186 shares,. Its Average Traded Price (ATP) is ₹927.75, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 50 @ ₹931.90.
Jubilant Pharmova has an upper circuit limit of ₹1118.60 and a lower circuit limit of ₹745.80. The total value traded stands at ₹11.43 CR, and the delivery percentage for the day is 72.62%.
The stock is currently traded with a market lot size of 1. Jubilant Pharmova also offers a dividend yield of 0.54%.
Jubilant Pharmova Share Price Chart
Jubilant Pharmova Share Key Metrics
Volume
1.23 L
Market Cap
14843.41 CR
LTQ@LTP
50@931.90
ATP
927.75
Var Margin
16.78 %
Circuit Range
745.8-1118.6
Delivery %
72.62 %
Value
11.43 CR
ASM/GSM
No
Market Lot
1
Jubilant Pharmova Fundamentals
P/E Ratio
42.17
P/B Ratio
2.08
Div. Yield
0.54
Sector P/E
41.36
Sector P/B
3.48
Sec. Div. Yield
0.53
Jubilant Pharmova Resistance and Support
Pivot 942.77
Resistance
First Resistance
964.04
Second Resistance
995.87
Third Resistance
1017.14
Support
First Support
910.94
Second Support
889.67
Third Support
857.84
Jubilant Pharmova Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 09 2026 | 940.4 | 931.9 | -0.03% | 950 | 917.6 |
| Thu Oct 08 2026 | 971 | 932.2 | -4.35% | 974.59 | 921.5 |
| Wed Oct 07 2026 | 991.2 | 974.59 | -1.48% | 993.79 | 971 |
Jubilant Pharmova Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-12 | To approve raising of funds |
| 2026-08-10 | Quarterly Results |
| 2026-08-07 | Quarterly Results |
| 2026-05-22 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-16 | Audited Results & Final Dividend |
| 2025-01-31 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
Jubilant Pharmova News
Jubilant Pharmova Ltd - 530019 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Jubilant Pharmova's subsidiary will invest CAD 94.5 million to modernize its Kirkland facility and double the production capacity of RUBY-FILL. The project is backed by a CAD 23.8 million financial support grant from the Government of Canada.
Oct 08 2026 21:23:50
Jubilant Pharmova Ltd - 530019 - Board Meeting Intimation for To Consider And Approve Raising Of Funds Through The Issuance Of Non-Convertible Debentures (Ncds) And/Or Such Other Securities As May Be Permitted Under Applicable Laws, And To Approve Seeking Shareholders'' Approval, As May Be Required
Jubilant Pharmova's board of directors will meet on October 12, 2026, to consider and approve raising funds through the issuance of Non-Convertible Debentures (NCDs). The board may also seek shareholder approval if required under applicable laws.
Oct 07 2026 19:43:27
Read More
Jubilant Pharmova Management
| Name | Position |
|---|---|
| Naresh Kapoor | Company Secretary & Compliance Officer |
| Shyam S Bhartia | Chairman |
Jubilant Pharmova Similar Stocks
Cohance Lifesciences Ltd.
441.00
-1.40 (0.32%)
Alembic Pharmaceuticals Ltd.
800.95
0.45 (0.06%)
Poly Medicure Ltd.
1587.10
-18.10 (1.13%)
Eris Lifesciences Ltd.
1170.70
15.60 (1.35%)
Natco Pharma Ltd.
789.40
-6.00 (0.75%)
Dr. Agarwal's Health Care Ltd.
477.75
6.75 (1.43%)
Vijaya Diagnostic Centre Ltd.
1436.60
5.50 (0.38%)
Marksans Pharma Ltd.
309.10
1.30 (0.42%)
Concord Biotech Ltd.
1361.40
30.60 (2.30%)
Sudeep Pharma Ltd.
1050.30
-64.60 (5.79%)
Jubilant Pharmova FAQs
The Buying Price of Jubilant Pharmova share is 931.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Jubilant Pharmova stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jubilant Pharmova, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Jubilant Pharmova shares is 42.17. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Jubilant Pharmova shares is 2.08. Useful to assess the stock's value relative to its book value.
To assess Jubilant Pharmova’s valuation compare Sector P/E, P/B which are 41.36 & 3.48 with sector averages, along with growth rates and financial metrics.
The Market Cap of Jubilant Pharmova is 14843.41 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Jubilant Pharmova share price is 1184.80 & 786.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Jubilant Pharmova belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in JUBLPHARMA
Or Download Choice FinX App
Invest in JUBLPHARMA
